About Rege Engredea Private Limited
Data last updated:
Rege Engredea Private Limited is a private limited company based in Nalgonda, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC089799. Its GSTIN is 36AAMCA6111H2ZS (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.87 Cr. It was formerly known as Arpan Herbikem Private Limited. It is led by directors Adarsh Patwari (Managing Director) and Anup Patwari.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Survey No. 572 Gundrampally Village Chityal Mandal, Nalgonda, Telangana, India – 508114.
As per the financials filed for FY 2018, the company reported a revenue of ₹1.91 Cr. For the same year it recorded a net loss of ₹39,673 (net margin -0.2%) and EBITDA of -₹39,673 (EBITDA margin -0.2%).
As per MCA filings, the company has open charges of ₹5.1 Cr on record. Court records list 12 cases involving the company, including 5 filed by the company and 6 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rege-engreda.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSurvey No. 572 Gundrampally Village Chityal Mandal, Nalgonda, Telangana, India – 508114
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rege Engredea Private Limited
The main business activity of Rege Engredea is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rege Engredea Private Limited FY 2018 filings available
Rege Engredea Private Limited reported revenue of ₹1.91 Cr for FY 2018.
Financial Statement Summary of Rege Engredea Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹39,673 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹39,673 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Rege Engredea Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.2% | •••• | •••• | •••• |
| Net Profit Margin | -0.2% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rege Engredea are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rege Engredea Private Limited
Rege Engredea Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medo Specia Pharma Private Limited | ₹1.92 Cr (FY 2021) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Meliorate Health Private Limited | ₹1.92 Cr (FY 2023) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Sreeven Pharma Private Limited | ₹1.92 Cr (FY 2025) | •••• | •••• | 284.0% | •••• | Hyderabad, Telangana, India |
| Phenomenon Nutritech Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 399.0% | •••• | Ahmedabad, Gujarat, India |
| Zenith Chemical Works Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Rege Engredea Private Limited this company | ₹1.91 Cr (FY 2018) | •••• | •••• | •••• | Nalgonda, Telangana, India | |
| Kan India Realtors Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Thane, Maharashtra, India |
| Laurel Pharmaceuticals Pvt Ltd | ₹1.91 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Jalandhar, Punjab, India |
| Avosia Pharma Private Limited | ₹1.9 Cr (FY 2025) | •••• | •••• | 247.0% | •••• | Bathinda, Punjab, India |
| Morksons Pharmaceuticals (India) Private Limited | ₹1.9 Cr (FY 2020) | •••• | •••• | -51.0% | •••• | New Delhi, Delhi, India |
| Indo-Swiss Remedies Private Limited | ₹1.89 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Rege Engredea by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rege Engredea Private Limited
Rege Engredea Private Limited is audited by B D SABOO & ASSOCIATES for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B D SABOO & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rege Engredea Private Limited
Rege Engredea has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anup Patwari | Director | 02 Sep 2013 | 13 Years 1 Months | Current |
| Adarsh Patwari | Managing Director | 02 Sep 2013 | 13 Years 1 Months | Current |
Ownership and Shareholding of Rege Engredea Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rege Engredea Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2018 | Syndicate Bank | ₹95 Lakh | Open |
| 10 Jun 2016 | Others | ₹4.15 Cr | Open |
Total charge records: 2 View all charges
Legal Cases of Rege Engredea Private Limited
Rege Engredea Private Limited has 12 court cases on record: 5 filed by Rege Engredea, 6 filed against it, 1 where it is another party. 3 cases are pending and 9 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 0 |
| District courts | 5 | 4 | 2 |
| NCLAT | 2 | 2 | 1 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, Chennai | Company appeal | Filed against the company by Eldorado Avenues Private Limited | Pending |
| NCLAT, Chennai | Interim or miscellaneous application | Filed against the company by Arunoday Life Spaces Private Limited | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against The Canara Bank Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (COS) | Company is another party | Pending |
| District court, Hyderabad CCC, Telangana | Court case (CC.NI) | Filed against the company by an individual | Pending |
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Rege Engredea Private Limited
Rege Engredea Private Limited has a workforce of 0 employees as of Mar 21, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Rege Engredea Private Limited
Rege Engredea has one previous CIN (Corporate Identification Number): U24232AP2013PTC089799. The current CIN is U24232TG2013PTC089799, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC089799 | Current |
| U24232AP2013PTC089799 | Previous |
Recent Activity on Rege Engredea Private Limited
Rege Engredea Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Adarsh Patwari ceased to be Director on 11 Jul 2016.
Credit Ratings, Litigation & Regulatory Alerts for Rege Engredea Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rege Engredea Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rege Engredea Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rege Engredea Private Limited
Rege Engredea has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCA6111H2ZS | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rege Engredea Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rege Engredea Private Limited
Rege Engredea is an active private limited company based in Nalgonda, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 September 2013 (13+ years old) and is registered under CIN U24232TG2013PTC089799.
Rege Engredea reported revenue of ₹1.91 Cr for FY 2018.
Rege Engredea has 2 current directors:
- Adarsh Patwari - Managing Director
- Anup Patwari - Director
Rege Engredea reported a net loss of ₹39,673 (net margin -0.2%) and EBITDA of -₹39,673 (EBITDA margin -0.2%) for FY 2018, as per its filed financial statements.
The GSTIN of Rege Engredea is 36AAMCA6111H2ZS, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Rege Engredea is U24232TG2013PTC089799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rege Engredea has 12 court cases on record: 5 filed by the company and 6 filed against it. 3 are pending. Most are in the high courts.
Rege Engredea was incorporated on 02 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rege Engredea by revenue are Medo Specia Pharma Private Limited, Meliorate Health Private Limited, Sreeven Pharma Private Limited, Phenomenon Nutritech Private Limited, Zenith Chemical Works Private Limited and 5 more, all in the Pharma industry (Formulations).
Adarsh Patwari ceased to be Director on 11 Jul 2016. Adarsh Patwari was appointed as Managing Director on 02 Sep 2013. Anup Patwari was appointed as Director on 02 Sep 2013.
Rege Engredea can be reached through the website rege-engreda.com. Its registered office is in Nalgonda, Telangana, India.